[EasyDNNnews:IfExists:Image]
![[EasyDNNnews:Title]]([EasyDNNnews:Image])
[EasyDNNnews:EndIf:Image]
[EasyDNNnews:SubTitle]
Actos—pioglitazone—is one of the best-selling drugs in the United States, used in the treatment of Type 2 diabetes. Actos gained FDA approval some thirteen years ago, and despite numerous reports of adverse health symptoms linked to Actos.
[EasyDNNnewsLocalizedText:Author]: [EasyDNNnews:Author:Link]
[EasyDNNnews:ArticleRating]
[EasyDNNnews:IfExists:Image]
[EasyDNNnews:EndIf:Image]
[EasyDNNnews:SubTitle]
Despite these negative reports, the sales of Actos continued to skyrocket with its manufacturer, Takeda, netting over $3 billion dollars for the sale of Actos in 2010 alone.
[EasyDNNnewsLocalizedText:Author]: [EasyDNNnews:Author:Link]
[EasyDNNnews:ArticleRating]
[EasyDNNnews:IfExists:Image]
[EasyDNNnews:EndIf:Image]
[EasyDNNnews:SubTitle]
Actos is a prescription drug manufactured by Takeda, a Japanese pharmaceutical corporation, over thirteen years ago and is used in the treatment of Type 2 diabetes. While there were many adverse health issues reported among users of Actos
[EasyDNNnewsLocalizedText:Author]: [EasyDNNnews:Author:Link]
[EasyDNNnews:ArticleRating]
[EasyDNNnews:IfExists:Image]
[EasyDNNnews:EndIf:Image]
[EasyDNNnews:SubTitle]
Nearly thirteen years ago a new diabetic drug, Actos, was approved for the treatment of Type 2 diabetes. Takeda, the Japanese manufacturer of Actos collaborated with Eli Lilly to release the drug in the United States at the time. At the same time Actos was approved, a close competitor, Avandia, was also approved.
[EasyDNNnewsLocalizedText:Author]: [EasyDNNnews:Author:Link]
[EasyDNNnews:ArticleRating]
[EasyDNNnews:IfExists:Image]
[EasyDNNnews:EndIf:Image]
[EasyDNNnews:SubTitle]
The drug Actos, marketed by Takeda Pharmaceutical Corporation, is used in the treatment of Type 2 diabetes. Actos largely replaced its predecessor, Avandia, after Avandia was found to have serious risks of heart attack and heart failure. At the time, it was believed that Actos offered much less risk of cardiovascular damage than Avandia. Actos is used to lessen blood glucose labels and improves how the body handles insulin.
[EasyDNNnewsLocalizedText:Author]: [EasyDNNnews:Author:Link]
[EasyDNNnews:ArticleRating]